View in EDS

Risk Assessment in Cardiovascular-Kidney-Metabolic Syndrome: An Opportunity to Individualize Evidence-Based Therapy in CKD.

Saved in:
Bibliographic Details
Title: Risk Assessment in Cardiovascular-Kidney-Metabolic Syndrome: An Opportunity to Individualize Evidence-Based Therapy in CKD.
Authors: Gregg LP; Section of Nephrology, Department of Medicine, Selzman Institute for Kidney Health, Baylor College of Medicine, Houston, Texas.; Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, Texas.; Renal Section, Medical Care Line, Michael E. DeBakey VA Medical Center, Houston, Texas., Bozkurt B; Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, Texas.; Section of Cardiology, Department of Medicine, Winters Center for Heart Failure Research, Baylor College of Medicine, Houston, Texas.; Medical Care Line, Michael E. DeBakey VA Medical Center, Houston, Texas., Navaneethan SD; Section of Nephrology, Department of Medicine, Selzman Institute for Kidney Health, Baylor College of Medicine, Houston, Texas.; Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, Texas.; Renal Section, Medical Care Line, Michael E. DeBakey VA Medical Center, Houston, Texas.; Institute of Clinical and Translational Research, Baylor College of Medicine, Houston, Texas.
Source: Clinical journal of the American Society of Nephrology : CJASN [Clin J Am Soc Nephrol] 2025 Dec 01. Date of Electronic Publication: 2025 Dec 01.
Publication Type: Journal Article
Journal Info: Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 101271570 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-905X (Electronic) Linking ISSN: 15559041 NLM ISO Abbreviation: Clin J Am Soc Nephrol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1555-905X
DOI:10.2215/CJN.0000000973